BEAM THERAPEUTICS INC.
26.86
08-November-24 14:07:27
15 minutes delayed
Stocks
+0.76
+2.91%
Today's range
25.68 - 27.04
ISIN
N/A
Source
NASDAQ
-
Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
05 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
29 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
06 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Announces Transition of Chief Financial Officer
15 Jul 2024 06:30:00 By Nasdaq GlobeNewswire
-
26 Jun 2024 06:30:00 By Nasdaq GlobeNewswire
-
14 Jun 2024 03:00:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
30 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
14 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
08 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
07 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
26 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences
28 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
27 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
08 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
14 Dec 2023 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference
08 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
08 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >